cigna glp-1 2025 reaches new deal on Eli Lilly and Novo Nordisk weight loss drugs Cigna will stop covering GLP-1
Description
Equip fitness pros to support clients on GLP-1 meds like Ozempic
Personalized plans and real medical support at every step.
A systematic comparison with other antidiabetic agents reveals notable differences in their influence on cancer risk across drug classes
Novo Nordisk the manufacturer of several GLP-1 receptor agonists such as liraglutide and semaglutide has said that it envisages intermittent supply shortages over the next 18 months.
